GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » PB Ratio

Zhaoke Ophthalmology (HKSE:06622) PB Ratio : 0.36 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zhaoke Ophthalmology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Zhaoke Ophthalmology's share price is HK$1.49. Zhaoke Ophthalmology's Book Value per Share for the quarter that ended in Dec. 2023 was HK$4.10. Hence, Zhaoke Ophthalmology's PB Ratio of today is 0.36.

Good Sign:

Zhaoke Ophthalmology Ltd stock PB Ratio (=0.36) is close to 1-year low of 0.36

The historical rank and industry rank for Zhaoke Ophthalmology's PB Ratio or its related term are showing as below:

HKSE:06622' s PB Ratio Range Over the Past 10 Years
Min: 0.36   Med: 0.39   Max: 0.74
Current: 0.36

During the past 5 years, Zhaoke Ophthalmology's highest PB Ratio was 0.74. The lowest was 0.36. And the median was 0.39.

HKSE:06622's PB Ratio is ranked better than
95.42% of 1310 companies
in the Biotechnology industry
Industry Median: 2.535 vs HKSE:06622: 0.36

During the past 12 months, Zhaoke Ophthalmology's average Book Value Per Share Growth Rate was -14.90% per year.

Back to Basics: PB Ratio


Zhaoke Ophthalmology PB Ratio Historical Data

The historical data trend for Zhaoke Ophthalmology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhaoke Ophthalmology PB Ratio Chart

Zhaoke Ophthalmology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - 1.01 0.63 0.96

Zhaoke Ophthalmology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only 1.01 0.75 0.63 0.82 0.96

Competitive Comparison of Zhaoke Ophthalmology's PB Ratio

For the Biotechnology subindustry, Zhaoke Ophthalmology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhaoke Ophthalmology's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhaoke Ophthalmology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhaoke Ophthalmology's PB Ratio falls into.



Zhaoke Ophthalmology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Zhaoke Ophthalmology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.49/4.102
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Zhaoke Ophthalmology  (HKSE:06622) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Zhaoke Ophthalmology PB Ratio Related Terms

Thank you for viewing the detailed overview of Zhaoke Ophthalmology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhaoke Ophthalmology (HKSE:06622) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangdong Province, Guangzhou, CHN
Zhaoke Ophthalmology Ltd is an ophthalmic pharmaceutical company. It is dedicated to the research, development, and commercialization of therapies that address unmet medical needs in China. The company has built a comprehensive ophthalmic drug pipeline of 26 candidates that covers ocular indications affecting the front and the back of the eye, through either in-house development or in-licensing. It has also established an ophthalmic manufacturing facility and is assembling an experienced marketing team in anticipation of a near-term product launch.
Executives
Mak Siu Hang Viola 2201 Interest of corporation controlled by you
Apstar Investment Pte Ltd 2201 Interest of corporation controlled by you
Coyote Investment Pte Ltd 2101 Beneficial owner
Gic (ventures) Pte. Ltd. 2201 Interest of corporation controlled by you
Gic Special Investments Private Limited 2102 Investment manager
Gic Private Limited 2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Vms Holdings Limited 2201 Interest of corporation controlled by you
Lee's Pharmaceutical Holdings Limited 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Holdings Iii-a, L.p. 2201 Interest of corporation controlled by you

Zhaoke Ophthalmology (HKSE:06622) Headlines

No Headlines